Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,411.00
Bid: 1,410.00
Ask: 1,412.00
Change: -7.00 (-0.49%)
Spread: 2.00 (0.142%)
Open: 1,412.00
High: 1,433.00
Low: 1,408.00
Prev. Close: 1,418.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Indivior Rises After Raising Guidance

Fri, 15th Jan 2021 11:21

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.

----------

FTSE 100 - WINNERS

----------

Aveva Group, up 6.0%. The industrial software provider said third-quarter revenue was boosted by contract renewals. In the three months to December 31, organic constant currency revenue grew by over 26%, AVEVA said. Following the "strong quarter of renewals", Aveva's revenue in the nine months ended December grew 1.5% annually, on an organic constant currency basis. "The board remains confident in the ful-year outlook for Aveva. Notwithstanding the disruption seen to the trading environment in 2020, the trend towards the digitalisation of the industrial world is strong, and the board remains excited about the significant growth opportunities ahead," the company added.

----------

Entain up 1.2%. The Ladbrokes-owner is in talks to appoint Jette Nygaard-Andersen as chief executive, which would make her the first woman to run a listed UK gambling group, Sky News reported late Thursday. Sky News said Nygaard-Andersen's appointment was not concluded and would likely be announced in the coming weeks. Nygaard-Andersen is already a non-executive director on the board of Entain, previously known as GVC.

----------

FTSE 250 - WINNERS

----------

Indivior, up 9.0%. The drugmaker upped its revenue guidance for last year amid good performance from an opioid addiction treatment. Indivior raised its 2020 revenue guidance to a range between USD645 million and GBP650 million from a previous guided range of USD595 million to GBP620 million. The guidance upgrade came as the FTSE 250-listed drug manufacturer lifted its annual net revenue guidance for opioid addiction treatment Sublocade to between USD128 million to GBP130 million from its previous forecast of USD120 million to GBP125 million. It noted that Sublocade has seen benefits from modest stocking activity in the US in the fourth quarter.

----------

Meggitt, up 2.5%. The aerospace parts maker backed a 2021 recovery for the civil aerospace sector, though added that it will take some time for passenger numbers and aftermarket activity to rebound. For Covid-19-battered 2020, Meggitt expects revenue to fall by a quarter to GBP1.7 billion from GBP2.28 billion in 2019. Underlying operating profit is expected to land in the middle of a GBP180 million and GBP200 million range, so less than half the GBP402.8 million from 2019. The aerospace industry has been hit by air travel restrictions. Carriers suffered but so too did aftermarket service providers such as Meggitt. Promisingly however for Meggitt, net debt is expected to be below the GBP911.2 million level reported as of the end of 2019.

----------

FTSE 250 - LOSERS

----------

Petrofac, down 20%. UK's Serious Fraud Office late Thursday said a former executive of the oilfield services company pleaded guilty to three counts of bribery. The company noted on Friday that no charges were brought against Petrofac or any other officers and employees. In connection with the SFO's ongoing investigation into Petrofac, David Lufkin, its former global head of sales, on Thursday pleaded guilty at Westminster Magistrates' Court to three counts of bribery. "A small number of former Petrofac employees are alleged to have acted together with the individual concerned, although none have been charged. No current board member of Petrofac Ltd is alleged to have been involved," the company said on Friday. The offences relate to corrupt offers and payments made between 2012 and 2018 to influence the award of contracts to Petrofac in the United Arab Emirates worth approximately USD3.3 billion, the SFO said in a statement on Thursday.

----------

Babcock International Group, down 15%. The defence contractor said the civil aviation market continued to struggle in its third quarter, as the sector was hit by a resurgent Covid-19, with prospects for its traditionally bumper final stretch of trading also uncertain. And in a worrying update on a "review of contract profitability and balance sheet", the firm cautioned on possible write-downs. Underlying revenue for the nine months to December 31 was GBP3.40 billion, down 4.9% from GBP3.57 billion a year earlier. Babcock said that excluding disposals and foreign exchange, revenue was down 3%. Underlying operating profit for the nine months was down 37% annually to GBP202 million from GBP320 million, or down 34% excluding forex and disposals.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Gama Aviation, up 10%. The business aviation service provider said its US subsidiary Gama Aviation Engineering has acquired Trenton, New Jersey-based Jet East Aviation from East Coast Aviation for USD7.7 million. Gama said its subsidiary will pay USD7.7 million upfront from its existing resources, with a further USD1 million in deferred cash payable over two years. It also will assume USD3.2 million of business aviation aircraft maintenance provider Jet East's debt. Gama Aviation said the acquisition will "substantially" enhance its already extensive maintenance capability within the US, capturing "further market share with 15,000 active business aviation aircraft."

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

N Brown Group, down 14%. The clothing retailer said the pace of annual revenue decline slowed in the third quarter, but warned that global container issues and other problems in its supply chain have caused stock delivery delays of up to three weeks. Revenue in the third quarter ended January 2 was down 8.8% annually, slowed from the second quarter's 13% fall and the 22% plunge in the first. The period included the crucial Christmas trading. Product revenue fell 8.9% year-on-year in the third-quarter. For N Brown's five strategic brands - JD Williams, Simply Be, Ambrose Wilson, Jacamo and Home Essentials - there was just a 1.4% slip. However, other brands - which include online-focused Fashion World, plus Premier Man, House of Bath, Marisota, Oxendales, High & Mighty, Figleaves - saw a 26% third-quarter revenue plunge.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
28 Oct 2021 12:17

Indivior lifts FY guidance as Q3 profits, revenue jump

(Sharecast News) - Indivior lifted its full-year guidance on Thursday as it reported a rise in third-quarter revenue and profit.

Read more
24 Oct 2021 17:12

Sunday share tips: Light Science Technologies, Indivior

(Sharecast News) - The Financial Mail on Sunday's Midas column told readers to buy shares of Light Science Technologies, pointing out the benefits of the company's technology for health, climate and the UK more economy.

Read more
31 Aug 2021 09:38

LONDON BROKER RATINGS: Citi and JPMorgan differ on Bridgepoint

LONDON BROKER RATINGS: Citi and JPMorgan differ on Bridgepoint

Read more
11 Aug 2021 16:08

Director dealings: Indivior director ups stake

(Sharecast News) - Indivior revealed on Wednesday that non-executive director Mark Stejbach had acquired 36,000 ordinary shares in the FTSE 250-listed pharmaceuticals business.

Read more
10 Aug 2021 15:07

DIRECTOR DEALINGS: 3i team buy; Scopia trims Indivior stake further

DIRECTOR DEALINGS: 3i team buy; Scopia trims Indivior stake further

Read more
9 Aug 2021 13:03

DIRECTOR DEALINGS: IntegraFin COO sells; Chaarat Gold chair buys

DIRECTOR DEALINGS: IntegraFin COO sells; Chaarat Gold chair buys

Read more
5 Aug 2021 15:29

DIRECTOR DEALINGS: Scopia slims 16% Indivior stake as chair buys

DIRECTOR DEALINGS: Scopia slims 16% Indivior stake as chair buys

Read more
4 Aug 2021 14:23

DIRECTOR DEALINGS: Robert Walters CEO sells GBP2.8 million in shares

DIRECTOR DEALINGS: Robert Walters CEO sells GBP2.8 million in shares

Read more
30 Jul 2021 12:28

IN BRIEF: Indivior to commence USD100 million share repurchase program

IN BRIEF: Indivior to commence USD100 million share repurchase program

Read more
29 Jul 2021 15:37

IN BRIEF: Indivior unveils profit hike and USD100 million buyback

IN BRIEF: Indivior unveils profit hike and USD100 million buyback

Read more
29 Jul 2021 12:13

LONDON MARKET MIDDAY: Investors cheer dividend hikes and buyback plans

LONDON MARKET MIDDAY: Investors cheer dividend hikes and buyback plans

Read more
29 Jul 2021 08:48

Indivior launches share buyback after strong first half

(Sharecast News) - Speciality pharmaceuticals company Indivior reiterated its upgraded guidance for 2021 on Thursday, and announced the start of a $100m (£71.71m) share buyback programme, as its first-half net revenue rose to $381m from $303m year-on-year.

Read more
22 Jul 2021 16:03

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
1 Jul 2021 14:00

Indivior agrees new loan facilities of USD250 million maturing in 2026

Indivior agrees new loan facilities of USD250 million maturing in 2026

Read more
1 Jul 2021 10:33

Indivior agrees to reprice and extend maturity of term loan facilities

(Sharecast News) - Pharmaceutical firm Indivior said on Thursday that it had entered into an amendment to reprice and extend the maturity of $250.0m worth of term loan facilities.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.